- Investing Ideas
- U.S. Pharmaceuticals & Biotech Sustainable Track Record
U.S. Pharmaceuticals & Biotech Sustainable Track Record
Results
14
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
14 companies
Incyte
Market Cap: US$24.4b
A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.
INCY
US$120.16
7D
-0.3%
1Y
38.2%
ACADIA Pharmaceuticals
Market Cap: US$4.9b
A biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America.
ACAD
US$28.24
7D
-3.3%
1Y
11.5%
Exelixis
Market Cap: US$12.7b
An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
EXEL
US$51.24
7D
-5.2%
1Y
33.8%
CareDx
Market Cap: US$2.3b
Provides solutions for improving outcomes for transplant patients and advancing organ health in the United States and internationally.
CDNA
US$45.32
7D
-2.9%
1Y
282.8%
CorMedix
Market Cap: US$587.7m
A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.
CRMD
US$7.54
7D
1.3%
1Y
-41.7%
Eli Lilly
Market Cap: US$1.1t
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.
LLY
US$1,180.16
7D
-0.5%
1Y
68.3%
Protalix BioTherapeutics
Market Cap: US$178.9m
A biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system.
PLX
US$2.22
7D
-9.8%
1Y
50.0%
Earth Science Tech
Market Cap: US$25.9m
Together with its subsidies, focuses on health and wellness industry.
ETST
US$0.09
7D
-8.1%
1Y
-56.1%
Rigel Pharmaceuticals
Market Cap: US$795.4m
A biotechnology company, develops and provides therapies that enhance the lives of patients with hematologic disorders and cancer in the United States.
RIGL
US$42.58
7D
6.0%
1Y
7.8%
Sotera Health
Market Cap: US$5.4b
Provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.
SHC
US$18.89
7D
0.2%
1Y
20.0%
Aurinia Pharmaceuticals
Market Cap: US$2.1b
A biopharmaceutical company, engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs in the United States and Japan.
AUPH
US$15.47
7D
-2.4%
1Y
26.1%
TG Therapeutics
Market Cap: US$6.9b
A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.
TGTX
US$48.74
7D
-2.0%
1Y
73.6%
Medpace Holdings
Market Cap: US$16.1b
Provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia.
MEDP
US$578.50
7D
-2.1%
1Y
26.4%
CapForce
Market Cap: US$46.4m
A precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally.
CFOR
US$3.75
7D
-16.7%
1Y
3,749,900.0%